Department of General Surgery, Shengjing Hospital of China Medical University, No.36 Sanhao Street, Shenyang, 100004, China.
BMC Cancer. 2019 Jun 25;19(1):622. doi: 10.1186/s12885-019-5835-6.
The aim of this study is to investigate the risk factors for the cervical lymph node metastasis in papillary thyroid carcinoma (PTC).
The clinicopathological data from the 966 PTC patients who underwent thyroid operation between January 2013 and December 2015 in the general surgery department of Shengjing Hospital of China Medical University were collected. The risk factors of predicting cervical lymph node metastasis were analyzed.
Male, age ≤ 45 years old, tumor size> 1.0 cm, extrathyroidal extension (ETE), US features as microcalcification, were independent risk factors for central lymph node metastasis (CLNM) (P < 0.05). Only CLNM was independent risk factors for lateral lymph node metastasis (LLNM) (P < 0.05). The ROC curve showed that the cutoff value of the number of CLNM for predicting lateral lymph node metastasis was defined as 2.5 (Sensitivity = 0.535, Specificity = 0.722, AUC = 0.669, P < 0.05). When the number of CLNM > 3, OR value was significantly higher, suggesting that the risk of LLNM increased significantly. The incidence of LLNM in level III (66.8%) and level IV (67.3%) were significantly higher than level II (42.2%) and level V (21.3%) (P < 0.05). The incidence of LLNM and skip metastasis in tumor located in the upper 1/3 of the lobe was the highest (P < 0.05).
Prophylactic central lymph node dissection should be performed in patients with risk factors as male, age ≤ 45 years old, tumor size> 1.0 cm, ETE and US features as microcalcification. Lateral lymph node dissection (LLND) should be more actively performed in patients with the number of CLNM> 3. Extent of LLND should include levels II, III, IV and V. Tumor located in the upper 1/3 of the lobe was vulnerable for LLNM and skip metastasis, so lymph node in lateral compartment should be noticed when lymph node status was preoperatively evaluated by imaging examination.
本研究旨在探讨甲状腺乳头状癌(PTC)颈淋巴结转移的危险因素。
收集中国医科大学盛京医院普外科 2013 年 1 月至 2015 年 12 月期间行甲状腺手术的 966 例 PTC 患者的临床病理资料。分析预测颈淋巴结转移的危险因素。
男性、年龄≤45 岁、肿瘤直径>1.0cm、甲状腺外侵犯(ETE)、超声表现为微钙化是中央淋巴结转移(CLNM)的独立危险因素(P<0.05)。只有 CLNM 是侧颈淋巴结转移(LLNM)的独立危险因素(P<0.05)。ROC 曲线显示,CLNM 数量预测侧颈淋巴结转移的截断值定义为 2.5(灵敏度=0.535,特异性=0.722,AUC=0.669,P<0.05)。当 CLNM 数目>3 时,OR 值显著升高,提示 LLNM 的风险显著增加。Ⅲ区(66.8%)和Ⅳ区(67.3%)的 LLNM 发生率明显高于Ⅱ区(42.2%)和Ⅴ区(21.3%)(P<0.05)。位于上 1/3 叶的肿瘤的 LLNM 和跳跃性转移发生率最高(P<0.05)。
对于男性、年龄≤45 岁、肿瘤直径>1.0cm、ETE 和超声表现为微钙化的患者,应进行预防性中央淋巴结清扫术。CLNM 数目>3 时应更积极行侧颈淋巴结清扫术(LLND)。LLND 的范围应包括Ⅱ、Ⅲ、Ⅳ和Ⅴ区。位于上 1/3 叶的肿瘤易发生 LLNM 和跳跃性转移,因此术前影像学检查评估淋巴结状态时应注意侧区淋巴结。